Welcome to our dedicated page for Naturl Alt Intl news (Ticker: NAII), a resource for investors and traders seeking the latest updates and insights on Naturl Alt Intl stock.
The Natural Alternatives International, Inc. (NAII) news page on Stock Titan aggregates company announcements, earnings releases, and regulatory updates for investors following this nutritional supplements manufacturer. NAI describes itself as a formulator, manufacturer, and marketer of customized nutritional supplements, with operations that include private-label contract manufacturing and patent and trademark licensing related to proprietary ingredients such as CarnoSyn® beta-alanine and TriBsyn™.
News items commonly include quarterly and annual financial results, where NAI reports net sales, segment performance for private-label contract manufacturing and CarnoSyn® beta-alanine royalty, licensing and raw material sales, and commentary on factors affecting profitability such as factory capacity utilization, sales mix, and operating costs. These releases also provide information on cash balances, working capital, and borrowing capacity under the company’s credit facility.
Investors can also find corporate and commercial updates, such as new or amended manufacturing agreements and distribution partnerships. For example, NAI has announced a multi-year Manufacturing Agreement with The Juice Plus+ Company covering capsule and powder products sold in over 24 markets, and a U.S. distribution agreement for TriBsyn™ with B&D Nutritional Ingredients. Such news highlights NAI’s customer relationships and the commercial rollout of its proprietary ingredients.
Another category of news covers product and scientific developments. NAI and CarnoSyn® Brands have issued press releases about clinical research on TriBsyn™, including a published study demonstrating increased beta-alanine bioavailability and elimination of paresthesia, as well as participation in scientific conferences like the ESPEN Congress on Clinical Nutrition & Metabolism.
By reviewing this news feed, readers can track NAII earnings announcements, material agreements, scientific milestones, and other company communications in one place.
Natural Alternatives International, Inc. (NAII) has announced that Jeff DaVanon has joined CarnoSyn® Brands as the Health & Wellness Business Development Manager. With over ten years of experience in the nutraceutical industry, DaVanon will enhance sales and customer relations for SR CarnoSyn®, focusing on wellness and healthy aging. His unique background as a former major league baseball player complements his extensive knowledge in nutraceuticals. This leadership change aims to capitalize on the growing wellness market, as CarnoSyn® Brands continues to expand its innovative product offerings.